The Comparison of Efficacy of Platelet Rich Plasma (PRP) with Methylprednisolone in Patients with Tennis Elbow

Iftikhar A. Memon; Sadaf Junejo; Kashif Mahmood Khan; Zulfiqar Ali; Siraj A. Butt; Faheem A. Memon

doi:10.51253/pafmj.v72iSUPPL-2.6842

Authors

Iftikhar A. Memon Liaquat University of Medical and Health Sciences, Jamshoro Pakistan
Sadaf Junejo National Institute of Child Health, Karachi Pakistan
Kashif Mahmood Khan Jinnah Postgraduate Medical Center, Karachi Pakistan
Zulfiqar Ali Liaquat University of Medical and Health Sciences, Jamshoro Pakistan
Siraj A. Butt Liaquat University of Medical and Health Sciences, Jamshoro Pakistan
Faheem A. Memon Liaquat University of Medical and Health Sciences, Jamshoro Pakistan

DOI:

https://doi.org/10.51253/pafmj.v72iSUPPL-2.6842

Keywords:

Elbow epicondylitis, Methylprednisolone, Orthopaedics, Platelet-rich plasma

Abstract

Objective: To study the efficacy of platelet-rich plasma with Methylprednisolone in patients with tennis elbow.

Study Design: Prospective longitudinal study.

Place and Duration of Study: Department of Orthopedics, Jinnah Postgraduate Medical Centre, Karachi, Feb 2019 to Sep 2020.

Methodology: All the patients with chronic lateral epicondylitis with the onset of symptoms of greater than three months were grouped into two groups. Seventy-six patients in each group were treated. Group-A received an injection of 5ml Platelet-rich plasma. Group-B was administered 1 ml of Methylprednisolone (dosage; 4-30 mg). The severity of pain using the visual analogue scale was evaluated at baseline.

Results: In the PRP group, significant changes in pain perception were observed. The mean baseline VAS score in the PRP group was 6.9 ± 1.7, which decreased to 3.4 ± 2.9, 1.7 ± 0.3, and 1.2 ± 1.4 at four weeks, 12 weeks, and 52 weeks follow-up visit, respectively. Similarly, in group-B (Methylprednisolone), there was a significant change from baseline to 52 weeks postprocedure (p<0.001). It was found that the efficacy of Platelet free plasma was significantly higher than methylprednisolone (77.6% versus 48.7%, <0.005).

Conclusions: The study concluded that Plasma rich platelet therapy was significantly more effective in relieving the pain and improving the functional outcomes in patients with elbow epicondylitis than Methylprednisolone.